Original price was: ₨120,000.00.₨105,000.00Current price is: ₨105,000.00.
Retalyx (Retatrutide Triple Agonist) 10mg Kwikpen
Retalyx is an advanced injectable pen by Regenesis Pharma, designed as a next-generation alternative to Mounjaro. Powered by Retatrutide, a cutting-edge triple-agonist formula, it offers superior benefits for both blood sugar management and weight loss in Pakistan.
Each Retalyx pen contains 10mg of active ingredient and is designed with 4 flexible doses, making it convenient and adaptable for different user needs. Customers can also microdose — taking smaller amounts per injection — allowing the pen to last longer while keeping hunger and food cravings under control.
Key Features:
Contains 40mg Retatrutide per pen
4-doses design (flexible use for multiple weeks)
Supports weight loss in Pakistan with advanced triple-agonist action
Can be split into smaller doses for personalized use
Designed to be a cost-effective alternative to Mounjaro
Convenient pen format for easy self-administration
Why Retalyx?
Retalyx is clinically inspired and formulated to replicate the results of the most advanced international therapies, but made more accessible and affordable for patients in Pakistan. With its unique mechanism of action, it helps suppress food noise, reduce appetite, improve insulin sensitivity, and support long-term fat loss.
Retalyx offers a smarter, more flexible way to approach both diabetes care and weight management, giving users the freedom to tailor their dosing strategy while achieving consistent results.
